IRIS
SALTARELLA, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.837
AS - Asia 1.567
EU - Europa 1.454
SA - Sud America 391
Continente sconosciuto - Info sul continente non disponibili 318
AF - Africa 96
OC - Oceania 2
Totale 7.665
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.691
SG - Singapore 618
IT - Italia 556
CN - Cina 308
BR - Brasile 306
RU - Federazione Russa 203
SE - Svezia 154
HK - Hong Kong 152
VN - Vietnam 145
DE - Germania 112
FR - Francia 103
BD - Bangladesh 91
FI - Finlandia 85
GB - Regno Unito 80
CA - Canada 64
IN - India 51
ID - Indonesia 48
BE - Belgio 30
ZA - Sudafrica 26
AR - Argentina 24
CI - Costa d'Avorio 24
PL - Polonia 23
LT - Lituania 22
MX - Messico 22
IQ - Iraq 19
CO - Colombia 18
TR - Turchia 18
MA - Marocco 17
JP - Giappone 16
VE - Venezuela 15
ES - Italia 14
PH - Filippine 14
NL - Olanda 13
SA - Arabia Saudita 11
AT - Austria 10
EC - Ecuador 10
JO - Giordania 10
UA - Ucraina 9
AE - Emirati Arabi Uniti 8
JM - Giamaica 8
TT - Trinidad e Tobago 8
UZ - Uzbekistan 8
PK - Pakistan 7
IE - Irlanda 6
MY - Malesia 6
NI - Nicaragua 6
AZ - Azerbaigian 5
GP - Guadalupe 5
GT - Guatemala 5
PR - Porto Rico 5
CH - Svizzera 4
CL - Cile 4
CR - Costa Rica 4
HN - Honduras 4
IR - Iran 4
KE - Kenya 4
RO - Romania 4
SC - Seychelles 4
SV - El Salvador 4
UY - Uruguay 4
AL - Albania 3
BH - Bahrain 3
BO - Bolivia 3
CW - ???statistics.table.value.countryCode.CW??? 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
IL - Israele 3
NO - Norvegia 3
PE - Perù 3
PY - Paraguay 3
RS - Serbia 3
TN - Tunisia 3
AU - Australia 2
BY - Bielorussia 2
CG - Congo 2
CY - Cipro 2
DZ - Algeria 2
EG - Egitto 2
HT - Haiti 2
HU - Ungheria 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
MT - Malta 2
NP - Nepal 2
PA - Panama 2
SN - Senegal 2
SY - Repubblica araba siriana 2
BB - Barbados 1
BG - Bulgaria 1
CU - Cuba 1
CV - Capo Verde 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GM - Gambi 1
KG - Kirghizistan 1
Totale 7.329
Salva come PNG Salva come JPEG
Città #
Ashburn 626
Singapore 356
San Jose 336
Fairfield 229
Chandler 219
Hong Kong 149
Woodbridge 148
Beijing 146
Nyköping 129
Milan 128
Council Bluffs 116
Seattle 116
New York 113
Cambridge 106
Ann Arbor 104
Houston 104
Los Angeles 102
Wilmington 102
Bari 77
Helsinki 67
Rome 59
Dallas 51
Lauterbourg 51
Santa Clara 46
Ho Chi Minh City 45
São Paulo 39
Munich 37
Jakarta 36
Brooklyn 35
Roxbury 31
Columbus 30
Lawrence 30
Brussels 29
Hanoi 26
Chicago 25
Nanjing 25
Abidjan 24
Dong Ket 23
Boardman 22
Falkenstein 22
Phoenix 22
Buffalo 21
Frankfurt am Main 20
Moscow 20
London 19
Des Moines 18
Johannesburg 17
Montreal 16
Tokyo 16
San Diego 15
The Dalles 15
Toronto 15
Washington 15
Dearborn 14
Orem 14
Stockholm 14
Grottaglie 13
Marseille 13
Turin 13
Warsaw 13
Denver 12
Inglewood 12
Salvador 12
Atlanta 11
Chennai 11
Turku 11
Amman 10
Curitiba 10
Florence 10
Naples 10
Rio de Janeiro 10
Paris 9
Princeton 9
Baghdad 8
Figino 8
Jacksonville 8
Manchester 8
Mexico City 8
Nuremberg 8
Poplar 8
Vienna 8
Basingstoke 7
Brasília 7
Guangzhou 7
Haiphong 7
Jiaxing 7
Vilnius 7
Bogotá 6
Bologna 6
Boston 6
Dublin 6
Managua 6
North Bergen 6
Palermo 6
San Francisco 6
Secaucus 6
Sorocaba 6
Tashkent 6
Venice 6
Ankara 5
Totale 4.802
Salva come PNG Salva come JPEG
Nome #
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 235
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 227
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 214
“Exosomes-Mediate Crosstalk in Multiple Myeloma progression and drug Resistance” 207
Identify multiple myeloma stem cells: Utopia? 200
Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review) 198
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial 197
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 197
Bortezomib treatment modulates autophagy in multiple myeloma 193
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 191
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 177
Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita 176
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 174
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 173
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 164
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 164
Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells 161
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 159
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma. 157
Inhibition of Notch mediated communication in endothelial and plasma cells reduces angiogenesis in multiple myeloma patients. 155
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 149
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 149
Inhibition of Notch-mediated crosstalk between endothelial cells and plasmacells reduces angiogenesis in multiple myeloma patients. 146
Inhibition of endothelial and plasma cells NOTCH mediated comunication reduces angiogenesis in multiple myeloma patients. 146
Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma 143
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 142
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 139
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 138
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 135
ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells 134
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 131
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 122
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance 121
Immersive and Non-Immersive Virtual Reality for Pain and Anxiety Management in Pediatric Patients with Hematological or Solid Cancer: A Systematic Review 114
Drug repurposing in skeletal muscle ion channelopathies 114
Notch cross-talk between endothelial cells and plasma cells in bone marrow of multiple myeloma patients 109
Antiangiogenic drugs as chemosensitizers in hematological tumors 108
Anti-Angiogenic Activity of Drugs in Multiple Myeloma 106
The “angiogenic switch” from MGUS to MM: what about the Notch role? 104
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 103
Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study 102
A c.1775C > T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia 102
null 101
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myeloma 96
Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management 96
Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels 95
Pharmacological therapy of non-dystrophic myotonias 93
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities 91
Pleiotropic Effects of the NSAID Fenamates on Chloride Channels: Opportunity for Ion Channelopathies? 87
Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives 87
Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma 82
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 79
NSAIDS AS MODULATORS OF CATION CHANNELS: FENAMATES REPURPOSING IN CHANNELOPATHIES 69
Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression 63
Jagged ligands enhance the pro-angiogenic activity of multiple myeloma cells 57
null 31
null 30
RhoB plays a central role in hyperosmolarity-induced cell shrinkage in renal cells 22
Electronic Devices and Digital Therapeutics in Neuromuscular Diseases: Narrative Review on Current Applications in Patients' Management and Pharmacovigilance 5
A novel KMT2A::AFF1-derived fusion circRNA regulates mitochondrial metabolism in t(4;11) B-cell acute lymphoblastic leukemia 5
Totale 7.665
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.995
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022238 0 0 0 11 9 18 18 16 23 22 40 81
2022/2023560 52 89 45 44 51 70 11 74 84 11 15 14
2023/2024305 15 34 18 23 48 114 8 7 5 7 8 18
2024/20251.318 47 24 63 64 90 115 239 156 48 67 155 250
2025/20263.023 394 124 170 265 333 200 348 87 371 289 135 307
2026/2027852 111 97 224 420 0 0 0 0 0 0 0 0
Totale 7.665